Smith+Nephew Opens S+N Academy Singapore

Smith+Nephew (S+N) has opened its S+N Academy Singapore, a medical education and digital innovation center covering the Asia Pacific region.
 
The S+N Academy Singapore offers an interactive training environment for healthcare professionals to experience the latest products and technologies, as well as refine techniques under the guidance of expert peers.
 
The facility has a digital operating suite including handheld robotics, 4K arthroscopy towers, surgical navigation tools, live transmission capabilities, and touch-screen interfaces. The digital experience is supported by a virtual reality simulation studio, tech-enabled teaching auditorium, and a professional broadcast studio where experts can record and live-stream surgical techniques to educate fellow healthcare professionals.
 
It also has fully equipped surgical super-stations for hands-on procedural training across Smith+Nephew’s entire portfolio of orthopedic reconstruction, trauma, robotics, sports medicine, ear, nose and throat and advanced wound management. It’s expected up to 3,500 healthcare providers will attend in-person courses at S+N Academy Singapore every year by 2025, with another 5,000 trained through digital technology.
 
Deepak Nath, CEO of Smith+Nephew, told the press: “We are proud to open S+N Academy Singapore which will provide the right environment and tools for thought leaders to challenge the status quo, refining new technologies and surgical techniques to improve outcomes for patients. We look forward to welcoming healthcare professionals to experience this unique medical innovation experience.”
 
Myra Eskes, President APAC and Global Service, Smith+Nephew, added: “Smith+Nephew has a strong and successful business in Asia-Pacific and ambitious growth plans to provide our medical technology to more surgeons and nurses. It is impossible to overstate the importance of education and hands-on experience as we take customers on this journey, and the new Academy will be vital in improving access to the latest innovation to drive better clinical outcomes.”